Recruiting NA Acne Scars

Compares treatment options for Acne Scars

Official title Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars

ClinicalTrials.gov ID: NCT07151599

What this study is testing

What it's testing
The purpose of this study is to compare two treatments for acne scars on the face. The study will test whether fractional lasers (Erbium:Glass and Thulium) lead to better improvement in acne scars than microneedling.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 45

You may be able to join if

  • Fitzpatrick skin phototypes I to VI
  • Presence of atrophic acne scars on the face

You likely can't join if

  • Decompensated systemic diseases
  • Any active infection (e.g., viral such as herpes, bacterial, or fungal)
  • Pregnant or breastfeeding women
  • Presence of hypertrophic or keloid scars
  • Current use of anticoagulant or antiplatelet medications
  • History of hemophilia or coagulation disorders
See the full eligibility criteria
Who can join
  • Fitzpatrick skin phototypes I to VI
  • Presence of atrophic acne scars on the face
What rules you out
  • Decompensated systemic diseases
  • Any active infection (e.g., viral such as herpes, bacterial, or fungal)
  • Pregnant or breastfeeding women
  • Presence of hypertrophic or keloid scars
  • Current use of anticoagulant or antiplatelet medications
  • History of hemophilia or coagulation disorders
  • Current use of anti-inflammatory drugs or corticosteroids
  • Use of retinoids, including isotretinoin, within the past 6 months
  • Exposure to sunlight within the past 15 days
  • Undergoing any aesthetic facial treatment or having undergone scar treatments in the facial region within 180 days prior to study initiation
  • Presence of active acne (occasional isolated lesions will not be considered exclusion criteria)

The study team makes the final eligibility decision.

Where it's taking place

  • São Paulo, Brazil

Compensation & support

A stipend or compensation may be offered.

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.